However, with the exception of loci such as SLC30A8 and KCNJ11-ABCC8, where the causal variants and effector transcripts have been validated through functional studies [11, 12], these labels are effectively arbitrary and offer no insight into the mechanisms through which GWAS signals impact on T2D susceptibility. The gene discussed is SLC30A8; the disease is type 2 diabetes mellitus.